Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T32880 | Target Info | |||
Target Name | HIF-prolyl hydroxylase 2 (HPH-2) | ||||
Synonyms | SM-20; Prolyl hydroxylase domain-containing protein 2; PHD2; Hypoxia-inducible factor prolyl hydroxylase 2; HPH-2; HIF-PH2; Egl nine homolog 1; C1orf12 | ||||
Target Type | Patented-recorded Target | ||||
Gene Name | EGLN1 | ||||
Biochemical Class | Paired donor oxygen oxidoreductase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Heat shock proteins | [+] 2 Heat shock proteins | + | |||
Interacting Target Name | Heat shock protein 90 alpha (HSP90A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigen NY-REN-38; LPS-associated protein 2; Lipopolysaccharide-associated protein 2; LAP-2; HSPCA; HSPC1; HSP90A; HSP86; HSP 86; Heat shock protein HSP 90-alpha; Heat shock 86 kDa | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [1] | |||
Interacting Target Name | Heat shock protein 90 beta (HSP90B) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HSP84; HSP 84; Heat shock 84 kDa | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [1] | |||
Isomerases | [+] 2 Isomerases | + | |||
Interacting Protein Name | Peptidyl-prolyl cis-trans isomerase FKBP8 (FKBP8) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | FKBP38; FKBPr38 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [3] | |||
3 | Affinity Capture-Western | [1] | |||
4 | Protein-peptide | [4] | |||
5 | Yeast two hybrid | [3] | |||
6 | Yeast two hybrid | [5] | |||
7 | Yeast two hybrid | [6] | |||
Interacting Protein Name | Prostaglandin E synthase 3 (PTGES3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P23; TEBP; cPGES | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [1] | |||
Transcription regulators | [+] 2 Transcription regulators | + | |||
Interacting Target Name | Hypoxia-inducible factor 1 alpha (HIF-1A) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor HIF-1; PASD8; PAS domain-containing protein 8; MOP1; Member of PAS protein 1; Hypoxia-inducible transcription factor (HIF)-1; Hypoxia-inducible factor 1-alpha; Hypoxia-inducible factor 1; Hypoxia inducible factor 1; HIF-1-alpha; HIF-1alpha; HIF1-alpha; HIF-1 alpha; HIF1 alpha; Class E basic helix-loop-helix protein 78; bHLHe78; Basic-helix-loop-helix-PAS protein MOP1; ARNT-interacting protein; ARNT interacting protein | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Affinity Capture-Western | [8] | |||
3 | Affinity Capture-Western | [9] | |||
4 | Affinity Capture-Western | [10] | |||
5 | Biochemical Activity | [11] | |||
6 | Co-crystal Structure | [12] | |||
7 | Reconstituted Complex | [13] | |||
8 | Yeast two hybrid | [14] | |||
Interacting Target Name | Hypoxia-inducible factor 2 alpha (HIF-2A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PASD2; PAS domain-containing protein 2; MOP2; Member of PAS protein 2; Hypoxia-inducible factor 2-alpha; HLF; HIF-2-alpha; HIF2-alpha; HIF2A; HIF-1-alpha-like factor; EPAS-1; Endothelial PAS domain-containing protein 1; Class E basic helix-loop-helix protein 73; bHLHe73; Basic-helix-loop-helix-PAS protein MOP2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Reconstituted Complex | [15] | |||
2 | Yeast two hybrid | [5] | |||
Other proteins | [+] 2 Other proteins | + | |||
Interacting Target Name | von Hippel-Lindau disease tumor suppressor (VHL) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | pVHL; Protein G7 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [16] | |||
2 | Reconstituted Complex | [17] | |||
Interacting Protein Name | Inhibitor of growth protein 4 (ING4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | p29ING4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [18] | |||
2 | Reconstituted Complex | [19] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Prolyl hydroxylase domain protein 2 (PHD2) binds a Pro-Xaa-Leu-Glu motif, linking it to the heat shock protein 90 pathway. J Biol Chem. 2013 Apr 5;288(14):9662-74. | ||||
REF 2 | Defective Tibetan PHD2 binding to p23 links high altitude adaption to altered oxygen sensing. J Biol Chem. 2014 May 23;289(21):14656-65. | ||||
REF 3 | The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability. Mol Cell Biol. 2007 May;27(10):3758-68. | ||||
REF 4 | Hypoxia-inducible factor prolyl-4-hydroxylase PHD2 protein abundance depends on integral membrane anchoring of FKBP38. J Biol Chem. 2009 Aug 21;284(34):23046-58. | ||||
REF 5 | Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response. Cancer Res. 2009 Jan 15;69(2):616-24. | ||||
REF 6 | Identification of Small-Molecule PHD2 Zinc Finger Inhibitors that Activate Hypoxia Inducible Factor. Chembiochem. 2016 Dec 14;17(24):2316-2323. | ||||
REF 7 | SIRT2 regulates tumour hypoxia response by promoting HIF-1 hydroxylation. Oncogene. 2015 Mar 12;34(11):1354-62. | ||||
REF 8 | pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner. Science. 2016 Aug 26;353(6302):929-32. | ||||
REF 9 | Phospholipase D1 protein coordinates dynamic assembly of HIF-1-PHD-VHL to regulate HIF-1 stability. Oncotarget. 2014 Dec 15;5(23):11857-72. | ||||
REF 10 | Phospholipase D2 promotes degradation of hypoxia-inducible factor-1 independent of lipase activity. Exp Mol Med. 2015 Nov 27;47:e196. | ||||
REF 11 | Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger. Mol Pharmacol. 2005 Dec;68(6):1803-9. | ||||
REF 12 | Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases. Structure. 2009 Jul 15;17(7):981-9. | ||||
REF 13 | Kinetic rationale for selectivity toward N- and C-terminal oxygen-dependent degradation domain substrates mediated by a loop region of hypoxia-inducible factor prolyl hydroxylases. J Biol Chem. 2008 Feb 15;283(7):3808-15. | ||||
REF 14 | Analysis of HIF-prolyl hydroxylases binding to substrates. Biochem Biophys Res Commun. 2006 Dec 15;351(2):313-20. | ||||
REF 15 | Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline. J Biol Chem. 2009 Apr 3;284(14):9050-8. | ||||
REF 16 | The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity. Nat Cell Biol. 2012 Jan 29;14(2):201-8. | ||||
REF 17 | RHOBTB3 promotes proteasomal degradation of HIF through facilitating hydroxylation and suppresses the Warburg effect. Cell Res. 2015 Sep;25(9):1025-42. | ||||
REF 18 | The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis. Blood. 2007 Dec 15;110(13):4464-75. | ||||
REF 19 | The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc Natl Acad Sci U S A. 2005 May 24;102(21):7481-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.